Connecting the DOT1L: it's EZH2
- PMID: 40504512
- DOI: 10.1182/blood.2025028711
Connecting the DOT1L: it's EZH2
Comment on
-
Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma.Blood. 2025 Jun 12;145(24):2873-2886. doi: 10.1182/blood.2024026534. Blood. 2025. PMID: 40009485
Publication types
LinkOut - more resources
Full Text Sources
